Stay updated with breaking news from Micro Biosystems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Codex DNA (NASDAQ:DNAY – Get Rating) and Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability and valuation. Earnings & Valuation This table compares Codex DNA […]
Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) and Pacific Biosciences of California (NASDAQ:PACB – Get Rating) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, risk, earnings, valuation and institutional ownership. Earnings & Valuation This table compares Rapid […]
Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Saturday, Zacks.com reports. The brokerage currently has a $7.00 price objective on the stock. Zacks Investment Research‘s target price points to a potential upside of 11.64% from the stock’s […]
Rapid Micro Biosystems (NASDAQ:RPID – Get Rating) had its target price dropped by research analysts at Morgan Stanley from $11.00 to $10.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Morgan Stanley’s price target suggests a potential upside of 73.61% from the […]
04.03.2022 - Reports fourth quarter 2021 total revenue of $5.2 million and commercial revenue of $4.9 million Reports full year 2021 total revenue of $23.2 million and commercial revenue of $21.6 million Reaffirms full year 2022 commercial revenue outlook ...